|
CDKL3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.7715611723761E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.55111512312578E-16 |
| Normal-vs-Stage2 |
3.95629999999647E-05 |
| Normal-vs-Stage3 |
1.21990000001571E-06 |
| Normal-vs-Stage4 |
7.85830000000765E-05 |
| Stage1-vs-Stage2 |
7.110200E-01 |
| Stage1-vs-Stage3 |
1.029620E-02 |
| Stage1-vs-Stage4 |
4.668000E-02 |
| Stage2-vs-Stage3 |
8.666200E-02 |
| Stage2-vs-Stage4 |
1.118440E-01 |
| Stage3-vs-Stage4 |
9.566600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.88178419700125E-16 |
| Normal-vs-AfricanAmerican |
1.178170E-03 |
| Normal-vs-Asian |
2.770600E-04 |
| Caucasian-vs-AfricanAmerican |
1.733580E-01 |
| Caucasian-vs-Asian |
8.382200E-01 |
| AfricanAmerican-vs-Asian |
4.211400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62481139653892E-12 |
| Normal-vs-Female |
1.20419999527499E-08 |
| Male-vs-Female |
2.774100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.966850E-01 |
| Normal-vs-Age(41-60Yrs) |
2.20423679309079E-12 |
| Normal-vs-Age(61-80Yrs) |
1.20392584790352E-12 |
| Normal-vs-Age(81-100Yrs) |
1.818210E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.915300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.796000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.085600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.505200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.656800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.375400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.295700E-02 |
| Normal-vs-Grade 2 |
2.88657986402541E-15 |
| Normal-vs-Grade 3 |
2.89512858131502E-12 |
| Normal-vs-Grade 4 |
2.443700E-02 |
| Grade 1-vs-Grade 2 |
7.368200E-01 |
| Grade 1-vs-Grade 3 |
3.966200E-01 |
| Grade 1-vs-Grade 4 |
2.083500E-02 |
| Grade 2-vs-Grade 3 |
2.131000E-01 |
| Grade 2-vs-Grade 4 |
4.25680000000206E-05 |
| Grade 3-vs-Grade 4 |
1.878780E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
2.844000E-04 |
| ccA subtype-vs-ccB subtype |
2.05160333166532E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.00524058363771E-12 |
| Normal-vs-N1 |
4.214800E-01 |
| N0-vs-N1 |
4.580000E-02 |
|
|
